BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33000154)

  • 1. Inherited Disorders of Lysine Metabolism: A Review.
    Bouchereau J; Schiff M
    J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
    Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
    Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of 2-aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1.
    Leandro J; Dodatko T; DeVita RJ; Chen H; Stauffer B; Yu C; Houten SM
    J Inherit Metab Dis; 2020 Nov; 43(6):1154-1164. PubMed ID: 32567100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.
    Biagosch C; Ediga RD; Hensler SV; Faerberboeck M; Kuehn R; Wurst W; Meitinger T; Kölker S; Sauer S; Prokisch H
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2220-2228. PubMed ID: 28545977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaric acidemia type 1.
    Hedlund GL; Longo N; Pasquali M
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):86-94. PubMed ID: 16602100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE).
    Pena IA; Marques LA; Laranjeira ÂB; Yunes JA; Eberlin MN; MacKenzie A; Arruda P
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):121-128. PubMed ID: 27615426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up.
    Stockler S; Plecko B; Gospe SM; Coulter-Mackie M; Connolly M; van Karnebeek C; Mercimek-Mahmutoglu S; Hartmann H; Scharer G; Struijs E; Tein I; Jakobs C; Clayton P; Van Hove JL
    Mol Genet Metab; 2011; 104(1-2):48-60. PubMed ID: 21704546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
    Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
    Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of urinary Δ¹-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in Antiquitin deficiency.
    Struys EA; Bok LA; Emal D; Houterman S; Willemsen MA; Jakobs C
    J Inherit Metab Dis; 2012 Sep; 35(5):909-16. PubMed ID: 22249334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Condensation of delta-1-piperideine-6-carboxylate with ortho-aminobenzaldehyde allows its simple, fast, and inexpensive quantification in the urine of patients with antiquitin deficiency.
    Boehm T; Hubmann H; Petroczi K; Mathis D; Klavins K; Fauler G; Plecko B; Struys E; Jilma B
    J Inherit Metab Dis; 2020 Jul; 43(4):891-900. PubMed ID: 31930735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into human lysine degradation pathways with relevance to pyridoxine-dependent epilepsy due to antiquitin deficiency.
    Crowther LM; Mathis D; Poms M; Plecko B
    J Inherit Metab Dis; 2019 Jul; 42(4):620-628. PubMed ID: 30767241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
    Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
    Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.
    Boy N; Mühlhausen C; Maier EM; Heringer J; Assmann B; Burgard P; Dixon M; Fleissner S; Greenberg CR; Harting I; Hoffmann GF; Karall D; Koeller DM; Krawinkel MB; Okun JG; Opladen T; Posset R; Sahm K; Zschocke J; Kölker S;
    J Inherit Metab Dis; 2017 Jan; 40(1):75-101. PubMed ID: 27853989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx.
    Strauss KA; Brumbaugh J; Duffy A; Wardley B; Robinson D; Hendrickson C; Tortorelli S; Moser AB; Puffenberger EG; Rider NL; Morton DH
    Mol Genet Metab; 2011; 104(1-2):93-106. PubMed ID: 21820344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridoxine-dependent epilepsy with elevated urinary α-amino adipic semialdehyde in molybdenum cofactor deficiency.
    Struys EA; Nota B; Bakkali A; Al Shahwan S; Salomons GS; Tabarki B
    Pediatrics; 2012 Dec; 130(6):e1716-9. PubMed ID: 23147983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin.
    Del Rizzo M; Galderisi A; Celato A; Furlan F; Giordano L; Cazzorla C; Fasan I; Moretti C; Zschocke J; Burlina AB
    Eur J Pediatr; 2016 Aug; 175(8):1123-8. PubMed ID: 26847429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision.
    Boy N; Mühlhausen C; Maier EM; Ballhausen D; Baumgartner MR; Beblo S; Burgard P; Chapman KA; Dobbelaere D; Heringer-Seifert J; Fleissner S; Grohmann-Held K; Hahn G; Harting I; Hoffmann GF; Jochum F; Karall D; Konstantopoulous V; Krawinkel MB; Lindner M; Märtner EMC; Nuoffer JM; Okun JG; Plecko B; Posset R; Sahm K; Scholl-Bürgi S; Thimm E; Walter M; Williams M; Vom Dahl S; Ziagaki A; Zschocke J; Kölker S
    J Inherit Metab Dis; 2023 May; 46(3):482-519. PubMed ID: 36221165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of astrocytic glutaminolysis in glutaric aciduria type I.
    Komatsuzaki S; Ediga RD; Okun JG; Kölker S; Sauer SW
    J Inherit Metab Dis; 2018 Jan; 41(1):91-99. PubMed ID: 29098534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials.
    van Karnebeek CD; Hartmann H; Jaggumantri S; Bok LA; Cheng B; Connolly M; Coughlin CR; Das AM; Gospe SM; Jakobs C; van der Lee JH; Mercimek-Mahmutoglu S; Meyer U; Struys E; Sinclair G; Van Hove J; Collet JP; Plecko BR; Stockler S
    Mol Genet Metab; 2012 Nov; 107(3):335-44. PubMed ID: 23022070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.